Ignite Creation Date:
2025-12-24 @ 6:58 PM
Ignite Modification Date:
2026-02-23 @ 8:07 PM
Study NCT ID:
NCT00349557
Status:
COMPLETED
Last Update Posted:
2014-07-16
First Post:
2006-07-05
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Bevacizumab With Hormonal and Radiotherapy for High-Risk Prostate Cancer
Sponsor:
Benaroya Research Institute
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
BRI 3031500
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
None
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None
Collaborators
Collaborators
| Name | Class | View |
|---|---|---|
| None | INDUSTRY | View |